COMMUNIQUÉS West-GlobeNewswire

Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
20/09/2019
PLANO, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective [...]
Novan Awarded Approximately $1.1 Million Grant by Department of Defense
20/09/2019
Funds to progress women’s health product candidate, WH504 Additive to recently announced NIH grant for WH602 Women’s health initiative to focus on potential HPV related onco-virus therapeutics MORRISVILLE, N.C., Sept. [...]
Anchiano Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
20/09/2019
CAMBRIDGE, Mass., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat [...]
XBiotech Announces Granting of Canadian Patent for Treatment of Dermatological Pathologies
20/09/2019
AUSTIN, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that the Canadian Patent Office has granted XBiotech a patent (Patent Number 56003542-6CA) covering the use of bermekimab in [...]
Adamas Announces New Safety and Efficacy Data for GOCOVRI® in Parkinson’s Disease Patients with Dyskinesia at the Movement Disorder Society 2019 International Congress
20/09/2019
EMERYVILLE, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system (CNS) [...]
Foamix Pharmaceuticals to Present at the Cantor Global Healthcare Conference
20/09/2019
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing [...]
CareDx Launches AlloSeq® Tx 17 at ASHI/BANFF Meeting
20/09/2019
AlloSeq Tx 17 is a best in class HLA typing solution with the most comprehensive sequencing and easiest workflow BRISBANE, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision [...]
GN announces changes to Executive Management
20/09/2019
GN Store Nord announces that Jakob Gudbrand has informed the company that he needs to resign from his position as CEO of GN Hearing for personal and family reasons. Gitte Pugholm Aabo, currently member of the Board of [...]
Tauriga Sciences, Inc. Partners with LEAFBUYER Technologies Inc. to Enhance its Social Media Presence and Increase its E-Commerce Revenue
20/09/2019
New York, NY, Sept. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
TG Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
20/09/2019
Presentation scheduled for Tuesday, September 24, 2019 at 11:00 AM ET NEW YORK, Sept. 20, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive [...]
MediPharm Labs Receives Organic Certification for Cannabis Oil and Extracts for Medical- and Adult-Use Markets
20/09/2019
TORONTO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid [...]
Evelo Biosciences to Host Key Opinion Leader Symposium on Unmet Need in Mild to Moderate Psoriasis and Potential for EDP1815
20/09/2019
CAMBRIDGE, Mass., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing orally delivered, systemically acting biologics, today announced that it [...]
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis
20/09/2019
CHMP recommends approval of Dupixent ® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis PARIS and TARRYTOWN, NY – September 20, 2019 – The European Medicines Agency’s Committee for Medicinal Products [...]
Sanofi : Le CHMP recommande l’approbation de Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère
20/09/2019
Le CHMP recommande l’approbation de Dupixent ® (dupilumab) dans le traitement de la polypose nasosinusienne sévère Paris et Tarrytown (New York) – Le 20 septembre 2019 – Le Comité des médicaments à usage humain (CHMP) [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0475 Per Share
20/09/2019
SAN JUAN CAPISTRANO, Calif., Sept. 20, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, [...]
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
20/09/2019
SAN FRANCISCO and TOKYO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (Nasdaq: FGEN, Interim CEO: James A. Schoeneck, “FibroGen”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “ [...]
FDA approves cobas Babesia, Roche’s first whole blood test for donor screening
20/09/2019
Roche is dedicated to helping save patients’ lives by delivering state-of-the-art solutions to aid in the protection of the global blood supply from infectious diseases If undetected, Babesia infection can be fatal in [...]
IBA subsidiary, Normandy Hadrontherapy, launches development of carbon therapy system in Normandy, France
20/09/2019
Louvain-La-Neuve, Belgium, 20 September 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the launch of the [...]
Normandy Hadrontherapy, filiale d'IBA, lance le développement d'un système de traitement par carbone en Normandie, en France
20/09/2019
Louvain-La-Neuve, Belgique, 20 septembre 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce le lancement aujourd'hui du [...]

Pages